Interesting indeed Karin, just as Ehrlich's "comprehensive update" on Kevetrin should be interesting in just a few days time.
Thanks to TP for digging up the Amgen connection and to Biohedge for his post earlier today.
If cohort 6 has completed dosing and results are available (and we now have two groups of "3"), I wonder if Shapiro and/or DF will allow those results to be reported?